 |
 |

Phosphodiesterase Type-5 Inhibitors and the Reemerging HIV Epidemic
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: The Commentary by Dr Jaffe and colleagues1 addressed the reemerging human immunodeficiency virus (HIV) epidemic among men who have sex with men in the United States. The authors describe substance abuse, particularly methamphetamines and alcohol, as one of the factors that contribute to unsafe sexual behaviors. Important substances of abuse that were not mentioned in the Commentary are phosphodiesterase type-5 inhibitors: sildenafil, vardenafil, and tadalafil. Phosphodiesterase type-5 inhibitors are indicated for the treatment of impotence but can enhance erectile function in the absence of clinical impotence and are often used in combination with other recreational drugs.2
In multiple surveys of US men who have sex with men, current or recent sildenafil use (with and without concomitant illicit drug use) was reported by 6% to 31% of respondents and was associated with increased rates of high-risk behaviors (eg, unprotected anal intercourse, HIV serodiscordant partners, and methamphetamine use) and . . . [Full Text of this Article]
Todd Hulgan, MD, MPH
todd.hulgan@vanderbilt.edu Vanderbilt University School of Medicine Nashville, Tennessee
Jeffrey D. Klausner, MD, MPH
San Francisco Department of Public Health University of California, San Francisco
RELATED ARTICLE
The Reemerging HIV/AIDS Epidemic in Men Who Have Sex With Men
Harold W. Jaffe, Ronald O. Valdiserri, and Kevin M. De Cock
JAMA. 2007;298(20):2412-2414.
EXTRACT
| FULL TEXT
|